Industry1d ago
FDA Pilots AI For Real-Time Trial Monitoring
The FDA is launching a pilot program using AI and cloud computing to monitor clinical trials in real time. This shift aims to shorten drug approval timelines by replacing manual oversight with automated data streams. The agency is deploying these tools to maintain operational capacity following DOGE layoffs. Practitioners can expect faster regulatory feedback loops.